Staphylococcus epidermidis ventriculitis treated with vancomycin and rifampin.

Area of Science:

• Infectious Diseases
• Neuroscience
• Pharmacology

Background:

• Ventriculitis, an infection of the brain's ventricles, poses significant treatment challenges.
• Staphylococcus epidermidis is an opportunistic pathogen frequently implicated in healthcare-associated infections, including central nervous system infections.
• Antistaphylococcal penicillins are a common first-line treatment for staphylococcal infections.

Observation:

• Two cases of ventriculitis caused by Staphylococcus epidermidis are presented.
• Both patients initially received antistaphylococcal penicillin therapy, which proved ineffective.
• The infections persisted despite standard antibiotic treatment.

Findings:

• A combination regimen of intravenous and intraventricular vancomycin and rifampin was administered.
• Both patients demonstrated a positive clinical response to the combination therapy.
• This highlights the efficacy of vancomycin and rifampin against resistant S. epidermidis.

Implications:

• Vancomycin and rifampin combination therapy is a crucial option for managing resistant central nervous system infections.
• This regimen is particularly important for infections caused by Staphylococcus epidermidis and methicillin-resistant Staphylococcus aureus (MRSA).
• Effective treatment strategies are vital for improving outcomes in patients with severe CNS infections.